Autologous Cell Therapy Global Research Report 2024: Market to Surge to $19.53 Billion by 2028, Propelled by Technological Advances and Aging Population Growth - Forecast to 2033
January 25, 2024 09:22 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Autologous Cell Therapy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global autologous cell therapy...
Autologous Cell Therapy Market to Hit USD 33.1 Billion by 2032; Amid Surging Demand From Personalized Treatments - Market.us
October 03, 2023 08:59 ET
|
Market.Us
New York, Oct. 03, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Autologous Cell Therapy Market size is expected to be worth around USD 33.1 Billion by 2032 from USD 5.5 Billion in 2022,...
Cell and Gene Therapy Manufacturing Services Market worth $26.72 Billion, Globally, by 2030 – Comprehensive Study by The Insight Partners
September 27, 2023 10:12 ET
|
The Insight Partners
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and commercial approval. Establishing...
Capacity Expansions and Strategic Collaborations Drive Significant Growth in the Global Cell and Gene Therapy Manufacturing Services Market
August 07, 2023 08:03 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing Services Market" report has been added to ResearchAndMarkets.com's offering.The global market for cell and gene...
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
May 02, 2023 16:35 ET
|
NKGen Biotech
SANTA ANA, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
NKGen Biotech Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Natural Killer Cell Therapies Targeting Neurodegenerative Diseases
March 08, 2023 13:27 ET
|
NKGen Biotech
SANTA ANA, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of natural killer (NK) cell...
Cell therapy Manufacturing Market to Surpass US$ 11,633.8 Million by 2030, Says Coherent Market Insights (CMI)
February 24, 2023 08:30 ET
|
CMI
Burlingame, Feb. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cell therapy manufacturing market is estimated to be valued at US$ 3,755.4 million in 2022 and is...
Cell & Gene Therapy Manufacturing Services Markets, 2022-2023 & 2027: Increasing Partnerships and Agreements Between Pharmaceutical Companies and CDMOs
February 10, 2023 06:58 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Manufacturing Services Market Report 2023" has been added to ResearchAndMarkets.com's offering. The global cell & gene...
Autologous Cell Therapy Market Report 2022: Growing Burden of Diseases Such as Cancer, Neurodegenerative Disorders & Autoimmune Disorders Fuels Demand
January 30, 2023 07:24 ET
|
Research and Markets
Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Source (Bone Marrow, Mesenchymal Stem Cells), By Application (Cancer,...
NKGen Biotech Appoints Paul Y. Song, MD as Chief Executive Officer
January 10, 2023 13:27 ET
|
NKGen Biotech
SANTA ANA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of natural killer cell therapies,...